AU6422298A - Pharmaceutical composition containing a phosphorylamide and an ayntibiotic - Google Patents
Pharmaceutical composition containing a phosphorylamide and an ayntibioticInfo
- Publication number
- AU6422298A AU6422298A AU64222/98A AU6422298A AU6422298A AU 6422298 A AU6422298 A AU 6422298A AU 64222/98 A AU64222/98 A AU 64222/98A AU 6422298 A AU6422298 A AU 6422298A AU 6422298 A AU6422298 A AU 6422298A
- Authority
- AU
- Australia
- Prior art keywords
- ayntibiotic
- phosphorylamide
- pharmaceutical composition
- composition containing
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- DMSZORWOGDLWGN-UHFFFAOYSA-N ctk1a3526 Chemical compound NP(N)(N)=O DMSZORWOGDLWGN-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7139197 | 1997-03-25 | ||
| JP9-71391 | 1997-03-25 | ||
| PCT/JP1998/001267 WO1998042347A1 (en) | 1997-03-25 | 1998-03-24 | Pharmaceutical composition containing a phosphorylamide and an ayntibiotic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6422298A true AU6422298A (en) | 1998-10-20 |
Family
ID=13459181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU64222/98A Abandoned AU6422298A (en) | 1997-03-25 | 1998-03-24 | Pharmaceutical composition containing a phosphorylamide and an ayntibiotic |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU6422298A (en) |
| WO (1) | WO1998042347A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004035560A1 (en) * | 2002-10-16 | 2004-04-29 | Nippon Soda Co.,Ltd. | Pyrrole derivative, intermediate, and agricultural or horticultural bactericide |
| UA105480C2 (en) | 2007-09-10 | 2014-05-26 | Янссен Фармацевтика Н.В. | Process for the preparation of compounds useful as inhibitors of sglt |
| US9056850B2 (en) | 2008-10-17 | 2015-06-16 | Janssen Pharmaceutica N.V. | Process for the preparation of compounds useful as inhibitors of SGLT |
| US20110009347A1 (en) | 2009-07-08 | 2011-01-13 | Yin Liang | Combination therapy for the treatment of diabetes |
| DK2488515T3 (en) | 2009-10-14 | 2017-02-27 | Janssen Pharmaceutica Nv | PROCEDURE FOR THE PREPARATION OF COMPOUNDS USED AS INHIBITORS OF SGLT2 |
| HUE029853T2 (en) | 2010-05-11 | 2017-04-28 | Janssen Pharmaceutica Nv | Pharmaceutical formulations comprising 1-(beta-d-glucopyranosyl)-2-thienylmethylbenzene derivatives as inhibitors of sglt |
| CA2832938C (en) | 2011-04-13 | 2019-09-03 | Janssen Pharmaceutica Nv | Process for the preparation of compounds useful as inhibitors of sglt2 |
| US9035044B2 (en) | 2011-05-09 | 2015-05-19 | Janssen Pharmaceutica Nv | L-proline and citric acid co-crystals of (2S, 3R, 4R, 5S,6R)-2-(3-((5-(4-fluorophenyl)thiopen-2-yl)methyl)4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
| US20170071970A1 (en) | 2015-09-15 | 2017-03-16 | Janssen Pharmaceutica Nv | Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders |
| CN106588868A (en) * | 2016-11-16 | 2017-04-26 | 武汉理工大学 | Synthesis method of 2-bromo-3-thiophenic acid intermediate |
| KR20220119651A (en) | 2019-12-20 | 2022-08-30 | 바이엘 악티엔게젤샤프트 | Substituted thiophene carboxamides, thiophene carboxylic acids and derivatives thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5899490A (en) * | 1981-10-19 | 1983-06-13 | Eisai Co Ltd | Phosphoric acid amide derivative, its preparation and pharmaceutical containing the same |
| EP0852498A1 (en) * | 1995-09-26 | 1998-07-15 | Takeda Chemical Industries, Ltd. | Phosphorylamides, their preparation and use |
-
1998
- 1998-03-24 WO PCT/JP1998/001267 patent/WO1998042347A1/en active Application Filing
- 1998-03-24 AU AU64222/98A patent/AU6422298A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998042347A1 (en) | 1998-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0002209A3 (en) | 4-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives and pharmaceutical compositions containing them | |
| IL191904A0 (en) | Pharmaceutical and compositions containing a?? fragments | |
| AU1618697A (en) | Novel compounds and pharmaceutical use thereof | |
| AU6740298A (en) | Pharmaceutical composition | |
| AU8865098A (en) | A composition and a product containing the same | |
| AUPN411195A0 (en) | Medicinal composition | |
| AU5136998A (en) | Medicinal composition | |
| AU5387898A (en) | Pharmaceutical agents | |
| AU6418596A (en) | Compounds and pharmaceutical compositions containing them | |
| AU7590096A (en) | Drug composition | |
| AU5880498A (en) | New benzolactam derivatives and medicinal compositions containing the same | |
| AU5856898A (en) | Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them | |
| AU5155096A (en) | Pharmaceutical composition | |
| AU7904998A (en) | Pharmaceutical composition containing peptichemio | |
| AU6747798A (en) | Hexanitrohexaazaisowurtzitane composition and explosive composition containing said composition | |
| AU6422298A (en) | Pharmaceutical composition containing a phosphorylamide and an ayntibiotic | |
| AU2531295A (en) | Pharmaceutical composition | |
| AU9343098A (en) | Pharmaceutical composition | |
| AU8695298A (en) | Compounds and uses thereof | |
| AU6119398A (en) | Phenylpropenone compounds and medicines containing the same | |
| AU4297297A (en) | Pharmaceutical composition containing a 5HT2c antagonist and a D2 antagonist | |
| AU7681498A (en) | Pharmaceutical composition and use thereof | |
| AU1509799A (en) | Pharmaceutical composition containing cyclosporin | |
| AU8693198A (en) | Compounds and uses thereof | |
| AU1258697A (en) | A pharmaceutical or veterinary composition |